Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

BeiGene Switzerland GmbH - Standard of Care is Not Enough! Talking Immunotherapy Clinical Trials in GI Cancers

Talking With Patients About Clinical Trials: How, What, Why, When and Where?

Date

10 Sep 2022

Session

BeiGene Switzerland GmbH - Standard of Care is Not Enough! Talking Immunotherapy Clinical Trials in GI Cancers

Topics

Patient Education and Advocacy;  Clinical Research;  Communication Skills;  Immunotherapy

Tumour Site

Oesophageal Cancer;  Gastric Cancer;  Hepatobiliary Cancers;  Colon and Rectal Cancer;  Gastro-Oesophageal Junction Cancer

Presenters

Lesley Fallowfield

Authors

L.J. Fallowfield

Author affiliations

  • Sussex Health Outcomes & Research In Cancer (shore-c), Brighton and Sussex Medical School - University of Sussex, BN1 9PX - Brighton/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.